外科領域におけるCS-1170の基礎的・臨床的検討 (CS-1170(CEFMETAZOLE:CMZ)論文特集)
スポンサーリンク
概要
- 論文の詳細を見る
Fundamental and clinical studies were conducted on CS-1170, and the following results were obtained.<BR>(1) Antibacterial activity<BR>The minimum inhibitory concentration of CS-1170 against ll strains of<I>E. coli</I>tested was 12.5μg/ml or less, which was far superior to that of cefazolin (CEZ). CS-1170 also demonstrated appreciable antibacterial activities against<I>Serratia.</I><BR>(2) Absorption and excretion<BR>Excretion of CS-1170 into bile was considered to be of the moderate group.<BR>(3) Clinical results<BR>CS-1170 was administered to 7 patients of surgical infections, and excellent response was observed in 1, case, good response in 4, fair in one and poor in one case. No subjective side effect was noted in any of the cases. As a result of the clinical examinations, a slight increase in Al-p value was found in one case, however, we could not determine whether this was attributable to CS-1170.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.